Concepedia

Correlation between morphology and EGFR mutations in lung adenocarcinomas

Hironori Ninomiya, Miyako Hiramatsu, Kentaro Inamura, Kimie Nomura, Michiyo Okui, Tatsu Miyoshi, Sakae Okumura, Yukitoshi Satoh, Ken Nakagawa, Makoto Nishio,

Lung Cancer · 2008 · 101 citations · 22 references

DOI

Concepts

References

22

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

, , +16

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations

, , +17

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Vincent A. Miller, Mark G. Kris, Jyoti D. Patel et al. · Journal of Clinical Oncology · 2004 · 746 citations

, , +16

The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.

Mark M. Moasser, Andrea Basso, Steven D. Averbuch et al. · PubMed · 2001 · 508 citations

, , +17

Micropapillary Component in Lung Adenocarcinoma

Mitual Amin, Pheroze Tamboli, Shakil H. Merchant et al. · The American Journal of Surgical Pathology · 2002 · 330 citations

, , +16